Logo image of BSTZ

BLACKROCK SCI & TECH TRM TR (BSTZ) Stock Price, Quote, News and Overview

NYSE:BSTZ - New York Stock Exchange, Inc. - US09260K1016 - Currency: USD

17.65  -0.09 (-0.51%)

After market: 16.0521 -1.6 (-9.05%)

Fundamental Rating

2

Overall BSTZ gets a fundamental rating of 2 out of 10. We evaluated BSTZ against 0 industry peers in the Unkown industry. BSTZ may be in some trouble as it scores bad on both profitability and health. BSTZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BSTZ was profitable.
In the past year BSTZ had a positive cash flow from operations.
Of the past 5 years BSTZ 4 years were profitable.
BSTZ had a positive operating cash flow in 4 of the past 5 years.
BSTZ Yearly Net Income VS EBIT VS OCF VS FCFBSTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Industry RankSector Rank
ROA 2.86%
ROE 2.94%
ROIC N/A
ROA(3y)-20.49%
ROA(5y)-1.37%
ROE(3y)-20.77%
ROE(5y)-1.25%
ROIC(3y)N/A
ROIC(5y)N/A
BSTZ Yearly ROA, ROE, ROICBSTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60 -80

1.3 Margins

In the last couple of years the Operating Margin of BSTZ has grown nicely.
The Operating Margin and Gross Margin are not available for BSTZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) -113.82%
GM N/A
OM growth 3Y57.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSTZ Yearly Profit, Operating, Gross MarginsBSTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, BSTZ has less shares outstanding
The debt/assets ratio for BSTZ is higher compared to a year ago.
BSTZ Yearly Shares OutstandingBSTZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M
BSTZ Yearly Total Debt VS Total AssetsBSTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 16.47 indicates that BSTZ is not in any danger for bankruptcy at the moment.
The Debt to FCF ratio of BSTZ is 0.02, which is an excellent value as it means it would take BSTZ, only 0.02 years of fcf income to pay off all of its debts.
BSTZ has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for BSTZ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 16.47
ROIC/WACCN/A
WACCN/A
BSTZ Yearly LT Debt VS Equity VS FCFBSTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 1B -1B 2B 3B

2.3 Liquidity

BSTZ has a Current Ratio of 0.40. This is a bad value and indicates that BSTZ is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.40 indicates that BSTZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
BSTZ Yearly Current Assets VS Current LiabilitesBSTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 121.46% over the past year.
BSTZ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -42.16% yearly.
The Revenue for BSTZ has decreased by -142.86% in the past year. This is quite bad
EPS 1Y (TTM)121.46%
EPS 3Y-42.16%
EPS 5YN/A
EPS Q2Q%129.02%
Revenue 1Y (TTM)-142.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%262.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BSTZ Yearly Revenue VS EstimatesBSTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 0 100M 200M 300M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.82, which indicates a rather cheap valuation of BSTZ.
Compared to an average S&P500 Price/Earnings ratio of 28.78, BSTZ is valued rather cheaply.
Industry RankSector Rank
PE 4.82
Fwd PE N/A
BSTZ Price Earnings VS Forward Price EarningsBSTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.54
EV/EBITDA N/A
BSTZ Per share dataBSTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.45%, BSTZ is a good candidate for dividend investing.
BSTZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 13.45%

5.2 History

BSTZ has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BSTZ Yearly Dividends per shareBSTZ Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

351.65% of the earnings are spent on dividend by BSTZ. This is not a sustainable payout ratio.
DP351.65%
EPS Next 2YN/A
EPS Next 3YN/A
BSTZ Yearly Income VS Free CF VS DividendBSTZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 500M -500M 1B -1B -1.5B
BSTZ Dividend Payout.BSTZ Dividend Payout, showing the Payout Ratio.BSTZ Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK SCI & TECH TRM TR

NYSE:BSTZ (4/28/2025, 11:46:07 AM)

After market: 16.0521 -1.6 (-9.05%)

17.65

-0.09 (-0.51%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners30.74%
Inst Owner Change0.42%
Ins Owners0.11%
Ins Owner Change11.94%
Market Cap1.28B
Analysts0
Price TargetN/A
Short Float %0.38%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 13.45%
Yearly Dividend1.85
Dividend Growth(5Y)N/A
DP351.65%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-15 2025-04-15 (0.22181)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.82
Fwd PE N/A
P/S N/A
P/FCF 6.54
P/OCF 6.54
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)3.66
EY20.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.7
FCFY15.29%
OCF(TTM)2.7
OCFY15.29%
SpS-0.59
BVpS22.87
TBVpS22.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 2.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) -113.82%
GM N/A
FCFM -456.91%
ROA(3y)-20.49%
ROA(5y)-1.37%
ROE(3y)-20.77%
ROE(5y)-1.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y57.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover-0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 401.44%
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 16.47
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)121.46%
EPS 3Y-42.16%
EPS 5YN/A
EPS Q2Q%129.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-142.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%262.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-201.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.99%
FCF growth 3Y17.39%
FCF growth 5YN/A
OCF growth 1Y-14.99%
OCF growth 3Y17.39%
OCF growth 5YN/A